Copyright
©The Author(s) 2023.
World J Gastroenterol. Nov 21, 2023; 29(43): 5818-5833
Published online Nov 21, 2023. doi: 10.3748/wjg.v29.i43.5818
Published online Nov 21, 2023. doi: 10.3748/wjg.v29.i43.5818
Table 8 Univariate and multivariate analysis of practice
Variables | Univariate analysis | Multivariate analysis | ||
OR (95%CI) | P value | OR (95%CI) | P value | |
Knowledge score (as continuous variables) | 1.10 (1.02-1.19) | 0.020 | 0.96 (0.87-1.06) | 0.412 |
Attitude score (as continuous variables) | 1.21 (1.13-1.30) | < 0.001 | 1.20 (1.11-1.30) | < 0.001 |
Gender | ||||
Male | 1.62 (0.86-3.04) | 0.134 | ||
Female | Ref | |||
Age | ||||
≤ 20 | Ref | |||
20-30 | 1.25 (0.45-3.50) | 0.672 | ||
30-40 | 1.65 (0.53-5.11) | 0.386 | ||
> 40 | 1.16 (0.41-3.30) | 0.780 | ||
Ethnicity | ||||
Han | 0.65 (0.14-3.11) | 0.589 | ||
Minorities | Ref | |||
Residence | ||||
Rural | Ref | Ref | ||
City | 2.41 (1.08-5.40) | 0.033 | 2.01 (0.80-5.04) | 0.139 |
Suburb/urban-rural combination | 1.12 (0.53-2.38) | 0.768 | 1.12 (0.49-2.58) | 0.788 |
Education | ||||
Primary school and below | Ref | |||
Middle school | 0.66 (0.20-2.22) | 0.503 | ||
High school/technical secondary school | 2.10 (0.56-7.84) | 0.272 | ||
Junior college/bachelor’s degree and above | 1.58 (0.49-5.11) | 0.441 | ||
Work status | ||||
Employed | 2.76 (1.41-5.40) | 0.003 | 1.93 (0.88-4.21) | 0.099 |
Other | Ref | Ref | ||
Monthly per capita income | ||||
< 5000 | Ref | Ref | ||
5000-10000 | 2.42 (1.06-5.51) | 0.036 | 1.31 (0.51-3.33) | 0.578 |
> 10000 | 1.71 (0.74-3.94) | 0.207 | 0.86 (0.32-2.28) | 0.755 |
Marital status | ||||
Unmarried or other | Ref | |||
Married | 0.65 (0.34-1.25) | 0.200 | ||
Smoking habit | ||||
No (no smoking) | Ref | |||
Yes (smoking or used to smoke) | 0.86 (0.41-1.84) | 0.706 | ||
Drinking habit | ||||
No (no drinking) | Ref | |||
Yes (drinking or used to drink) | 1.18 (0.60-2.35) | 0.631 | ||
What kind of IBD is being diagnosed | ||||
Ulcerative colitis | 0.80 (0.43-1.52) | 0.501 | ||
Crohn’s disease | Ref | |||
Duration of IBD | ||||
< 1 yr | 1.39 (0.59-3.27) | 0.445 | ||
1-2 yr | 0.74 (0.27-2.01) | 0.558 | ||
> 2 yr | Ref | |||
Ostomy | ||||
Yes | 0.62 (0.22-1.72) | 0.354 | ||
No | Ref | |||
Comorbidities | ||||
Yes | 0.43 (0.21-0.88) | 0.022 | 0.50 (0.23-1.09) | 0.082 |
None | Ref | Ref | ||
Family history of IBD | ||||
Yes | - | - | ||
No | Ref | |||
Surgical history | ||||
Yes | 1.11 (0.59-2.09) | 0.741 | ||
No | Ref | |||
History of drug allergy | ||||
Yes | 0.83 (0.35-1.99) | 0.682 | ||
No | Ref | |||
What kind of treatment is being received? | ||||
5-aminosalicylic acid drugs (e.g., mesalazine) | Ref | |||
Glucocorticoids | - | - | ||
Immunosuppressants (e.g., azathioprine, tacrolimus, cyclosporine, etc.) | 0.19 (0.02-1.41) | 0.104 | ||
Biological agents (e.g., infliximab, vedolizumab, ustekinumab) | 1.38 (0.38-4.97) | 0.622 | ||
Biological agents + immunosuppressants | 2.44 (0.23-26.30) | 0.463 | ||
Biological agents + 5-aminosalicylic acid drugs | 0.94 (0.13-6.63) | 0.948 |
- Citation: Shao XX, Fang LY, Guo XR, Wang WZ, Shi RX, Lin DP. Knowledge, attitude, and practice of patients living with inflammatory bowel disease: A cross-sectional study. World J Gastroenterol 2023; 29(43): 5818-5833
- URL: https://www.wjgnet.com/1007-9327/full/v29/i43/5818.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i43.5818